Amneal Pharmaceuticals Investor Relations Material
Latest events
Q2 2024
Amneal Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Amneal Pharmaceuticals Inc
Access all reports
Amneal is a full-service pharmaceutical company focused on the development, licensing, manufacturing and marketing of generic, branded specialty pharmaceutical products. This includes all aspects of product development from drug research and clinical trials through approval; all phases of manufacture from preclinical development to commercial production, including validations and supply chain management; and distribution to the company's customers worldwide.
Key slides for Amneal Pharmaceuticals Inc
Q2 2024
Amneal Pharmaceuticals Inc
Q2 2024
Amneal Pharmaceuticals Inc
Latest articles
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
Novo Nordisk: The Danish Pharmaceutical Titan Revolutionizing Global Healthcare
Novo Nordisk's rise to becoming Europe's largest company, reshaping global healthcare and Denmark's economy.
5 Sep 2024
The Toyota Way: Revolutionizing Global Manufacturing
Explore how Toyota's Lean Manufacturing and Kaizen principles revolutionized production and quality, setting global benchmarks for excellence.
2 Sep 2024
Ticker symbol
AMRX
Country
🇺🇸 United States